Clin2
NCT07766369Possibly a fitRecruiting

Drug interaction study for healthy adults

Healthy Volunteers

This trial tests how a new drug, E2086, interacts with other medicines in healthy volunteers. It helps make sure the drug is safe and works properly when combined with common medications.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
93 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You do not smoke or vape.
  • Your body mass index (BMI) is between 18 and 30.
  • You are generally healthy with no significant medical conditions.
  • You have no history of psychiatric disorders or suicidal thoughts.
  • Women must not be pregnant or breastfeeding and must use effective birth control.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07674940Recruiting· Phase 1
Study of a new drug at different doses in healthy people

This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.

Miramar, Florida
NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah
NCT07162441Recruiting· Phase 1
Drug interaction study in healthy volunteers

This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.

Seoul, Gwanak-gu
NCT07412353Recruiting· Phase 1
Testing safety of single dose SYH2085 in healthy people

This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.

Shanghai, Shanghai Municipality
NCT07640438Recruiting· Phase 1
Safety Study of New Drug in Healthy Adults

This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.

Hangzhou, Zhejiang
NCT07771777Not yet recruiting· Phase 1
Safety study of the drug SYH2056 in healthy volunteers

This early-phase trial tests a new drug, SYH2056, in healthy people to see how safe it is and how the body handles it. The study will also look at how food affects the drug. If you are generally healthy, this could be a way to contribute to medical research.

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.